GB0209889A
GB0209889D0
(en)
|
2002-04-30 |
2002-04-30 |
Organic compounds
|
TW092109911A
TW200403066A
(en)
|
2002-04-30 |
2003-04-28 |
New uses of substituted aminoalkanephosphonic acids
|
MXPA04010816A
MXPA04010816A
(en)
|
2002-04-30 |
2003-04-29 |
New uses of substituted aminoalkanephosphonic acids.
|
CA002482524A
CA2482524A1
(en)
|
2002-04-30 |
2003-04-29 |
Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders
|
EP03747434A
EP1501518A2
(en)
|
2002-04-30 |
2003-04-29 |
Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders
|
PL03371427A
PL371427A1
(en)
|
2002-04-30 |
2003-04-29 |
New uses of substituted aminoalkanephosphonic acids
|
US10/512,923
US20060293282A1
(en)
|
2002-04-30 |
2003-04-29 |
Substituted aminoalkanephosphonic acids
|
KR10-2004-7017470A
KR20040101573A
(en)
|
2002-04-30 |
2003-04-29 |
Substituted Aminoalkanephosphonic Acids for the Treatment of Neuropathic Pain, Affective and Attention Disorders, Schizophrenia, Tinnitus, Myopia and Other Ocular Disorders
|
AU2003232224A
AU2003232224B2
(en)
|
2002-04-30 |
2003-04-29 |
Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia, and other ocular disorders
|
PCT/EP2003/004466
WO2003092701A2
(en)
|
2002-04-30 |
2003-04-29 |
Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders
|
JP2004500885A
JP2005527600A
(en)
|
2002-04-30 |
2003-04-29 |
Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, emotional and attention deficits, schizophrenia, tinnitus, myopia and other eye disorders
|
CNA038095971A
CN1649599A
(en)
|
2002-04-30 |
2003-04-29 |
Substituted aminoalkanephosphonic acids for the treatment ofneuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders
|
BR0309611-4A
BR0309611A
(en)
|
2002-04-30 |
2003-04-29 |
Substituted aminoalkanophosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, ringing in the ear, myopia and other eye disorders.
|
IL16477904A
IL164779A0
(en)
|
2002-04-30 |
2004-10-21 |
Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other oculat disorders
|
NO20045089A
NO20045089L
(en)
|
2002-04-30 |
2004-11-23 |
Substituted amino alkano phosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders
|
JP2009012152A
JP2009137995A
(en)
|
2002-04-30 |
2009-01-22 |
Substituted aminoalkanephosphonic acid for treating neuropathic pain, affective and attention disorder, schizophrenia, tinnitus, myopia and other ocular disorder
|